Associate Director​/Director, Financial Reporting

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.

Full Time Director San Diego, CA, San Diego, CA, US

Salary Range: $ To $ Annually

ADARx Pharmaceuticals, Inc., (the “Company” or “ADARx”) located in San Diego, is a clinical stage biotechnology company dedicated to transforming cutting-edge science into next-generation RNA therapeutics to treat a broad spectrum of diseases. Our goal is to control the expression of specific disease drivers with highly selective RNA targeted therapies, delivering life-changing treatments for patients with urgent unmet medical needs.

The Associate Director/Director, Financial Reporting will serve as a hands-on accounting leader responsible for building and leading ADARx’s external financial reporting and technical accounting functions as the Company prepares to operate in a public-company environment. Reporting to the Senior Director, Corporate Controller, this individual will lead SEC reporting, financial statement preparation, technical accounting analyses, disclosure controls, and internal controls over financial reporting.

The role will partner closely with accounting, finance, legal, human resources, external auditors, outside counsel, and other business leaders. The final title will be determined based on the selected candidate’s experience and qualifications. This position is based at the Company’s office in San Diego, California.

• Leadthe preparation, review, and filing of Forms 10-Q and 10-K,the annual proxy statement, registration statements,and other SEC filings in accordance with U.S. GAAP and SEC requirements.
• Lead the drafting and review of financial statements, footnote disclosures, MD&A, and other financial sections of SEC filings; manage the reporting calendarandreview process; and ensure filings are accurate, complete, internally consistent, and submitted on schedule.
• Coordinate with the accounting team to ensure the close process, account analyses, and supporting schedules provide complete and accurate support for internal and external financial reporting.
• Review key general ledger accounts, journal entries, account reconciliations, and supporting schedules to ensure accuracy, completeness, appropriate documentation, and timely resolution of identified issues.
• Support and review the end-to-end equity accounting and administration process, including stock-based compensation, equity transactions, share and award activity, reconciliations between the equity administration platform and general ledger, and related financial statement disclosures.
• Lead the evaluation of complex and nonroutine transactions under U.S. GAAP, including equity-based compensation, debt and equity transactions, collaboration and licensing arrangements, research and development arrangements, leases, and other matters relevant to a clinical-stage biotechnology company.
• Prepare and maintain technical accounting memoranda and supporting documentation that clearly articulate the relevant facts, authoritative guidance, analyses, judgments, and conclusions.
• Develop, document, and maintain scalable SEC reporting policies, procedures, disclosure controls, and internal controls over financial reporting, including controls that support SOX readiness and future compliance; review related business processes and technology-dependent controls that affect the Company’s broader control environment.
• Serve as a primary accounting contact for external auditors and coordinate with outside counsel, tax advisors, valuation specialists, and other service providers on financial reporting, audit, and technical accounting matters.
• Prepare…